105 related articles for article (PubMed ID: 9473792)
1. Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes.
Mrázová-Studená M; Drgona L; Spánik S; Krúpová I; Baláz M; Pichna P; Koren P; Sufliarsky J; Mardiak J; Kunová A; Trupl J; Krcméry V
Neoplasma; 1997; 44(5):314-8. PubMed ID: 9473792
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.
Spánik S; Trupl J; Kunová A; Pichna P; Helpianska L; Ilavská I; Kukucková E; Lacka J; Grausová S; Stopková K; Drgona L; Krcméry V
Neoplasma; 1996; 43(4):235-8. PubMed ID: 8931747
[TBL] [Abstract][Full Text] [Related]
3. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
Cornillet A; Camus C; Nimubona S; Gandemer V; Tattevin P; Belleguic C; Chevrier S; Meunier C; Lebert C; Aupée M; Caulet-Maugendre S; Faucheux M; Lelong B; Leray E; Guiguen C; Gangneux JP
Clin Infect Dis; 2006 Sep; 43(5):577-84. PubMed ID: 16886149
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
[TBL] [Abstract][Full Text] [Related]
5. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
6. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
Akova M; Paesmans M; Calandra T; Viscoli C;
Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and outcome for breakthrough candidaemia in patients with cancer.
Chung JW; Lee SO; Choi SH; Woo JH; Ryu J; Kim YS; Kim NJ
Mycoses; 2006 Mar; 49(2):114-8. PubMed ID: 16466444
[TBL] [Abstract][Full Text] [Related]
8. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
9. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
[TBL] [Abstract][Full Text] [Related]
10. Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Krcmery V; Trup J; Kunova A; Spanik S; Drgona L; Oravcova E; Studena M; Lacka J; Sevcikova L; Koren P; Kukuckova E; Stopkova K; Krupova I; Grausova S; Svec J
Int J Clin Pharmacol Res; 1996; 16(2-3):43-9. PubMed ID: 9063755
[TBL] [Abstract][Full Text] [Related]
11. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
12. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.
Boktour M; Hanna H; Ansari S; Bahna B; Hachem R; Tarrand J; Rolston K; Safdar A; Raad I
Cancer; 2006 May; 106(9):1967-73. PubMed ID: 16565968
[TBL] [Abstract][Full Text] [Related]
13. Bacteremia in febrile nonneutropenic pediatric oncology patients.
Kelly MJ; Vivier PM; Panken TM; Schwartz CL
Pediatr Blood Cancer; 2010 Jan; 54(1):83-7. PubMed ID: 19774640
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Spanik S; Trupl J; Ilavska I; Helpianska L; Drgona L; Demitrovicova A; Kukuckova E; Studena M; Pichna P; Oravcova E; Rusnakova V; Koren P; Lacka J; Krcmery V
J Chemother; 1996 Oct; 8(5):387-93. PubMed ID: 8957720
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.
Abidi MZ; Ledeboer N; Banerjee A; Hari P
Diagn Microbiol Infect Dis; 2016 May; 85(1):116-20. PubMed ID: 26906191
[TBL] [Abstract][Full Text] [Related]
17. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
Anatoliotaki M; Valatas V; Mantadakis E; Apostolakou H; Mavroudis D; Georgoulias V; Rolston KV; Kontoyiannis DP; Galanakis E; Samonis G
Infection; 2004 Apr; 32(2):65-71. PubMed ID: 15057569
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia and fungemia in cancer patients with venous catheters.
Kukucková E; Studená M; Trupl J; Svec J; Kunová A; Sufliarsky J; Sorkovská D; Minárik T; Sycová Z; Krcméry V
Neoplasma; 1995; 42(1):35-8. PubMed ID: 7617073
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
